These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20920601)

  • 1. Current-to-load mismatch, Brugada ECG pattern, and the associated arrhythmogenesis.
    Di Diego JM
    Heart Rhythm; 2011 Jan; 8(1):119-20. PubMed ID: 20920601
    [No Abstract]   [Full Text] [Related]  

  • 2. ST segment elevation by current-to-load mismatch: an experimental and computational study.
    Hoogendijk MG; Potse M; Vinet A; de Bakker JM; Coronel R
    Heart Rhythm; 2011 Jan; 8(1):111-8. PubMed ID: 20870038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ajmaline challenge: to stop or not to stop..
    Probst V; Le Marec H
    Heart Rhythm; 2009 May; 6(5):632-3. PubMed ID: 19389650
    [No Abstract]   [Full Text] [Related]  

  • 4. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
    Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
    Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug challenge with sodium-channel blockade: improving phenotypic characterization of early repolarization.
    Ilkhanoff L; Knight BP
    Heart Rhythm; 2012 Feb; 9(2):240-1. PubMed ID: 21964324
    [No Abstract]   [Full Text] [Related]  

  • 6. Ajmaline attenuates electrocardiogram characteristics of inferolateral early repolarization.
    Roten L; Derval N; Sacher F; Pascale P; Wilton SB; Scherr D; Shah A; Pedersen ME; Jadidi AS; Miyazaki S; Knecht S; Hocini M; Jaïs P; Haïssaguerre M
    Heart Rhythm; 2012 Feb; 9(2):232-9. PubMed ID: 21914496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
    Wolpert C; Echternach C; Veltmann C; Antzelevitch C; Thomas GP; Spehl S; Streitner F; Kuschyk J; Schimpf R; Haase KK; Borggrefe M
    Heart Rhythm; 2005 Mar; 2(3):254-60. PubMed ID: 15851314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome.
    Nattel S
    Heart Rhythm; 2005 Mar; 2(3):261-2. PubMed ID: 15851315
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical effect of ajmaline in a patient with Brugada syndrome.
    Sassone B; Saccà S; Donateo M
    Europace; 2006 Apr; 8(4):251-4. PubMed ID: 16627450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Provocation of Outflow-Tract Tachycardia in a Patient With Brugada Syndrome.
    Bürkle G; Schäfer H; Marschall C; Brugada P; Ehrlich JR
    Can J Cardiol; 2016 Dec; 32(12):1577.e5-1577.e7. PubMed ID: 27032887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combinations of anti-arrhythmia agents and the heart conduction system].
    Pleskot M; Tilser P; Pidrman V
    Vnitr Lek; 1988 Jan; 34(1):23-30. PubMed ID: 3354214
    [No Abstract]   [Full Text] [Related]  

  • 14. Brugada-like phenomenon, induced by intravenous propafenone, in a patient with idiopathic fascicular ventricular tachycardia.
    Pino R; Sciortino G; Polizzi G
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):380-3. PubMed ID: 20414118
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of Brugada type I to type III and successful control of recurrent ventricular arrhythmia with cilostazol.
    Ağaç MT; Erkan H; Korkmaz L
    Arch Cardiovasc Dis; 2014; 107(8-9):476-8. PubMed ID: 23791603
    [No Abstract]   [Full Text] [Related]  

  • 16. Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial.
    Ensam B; Scrocco C; Johnson D; Wijeyeratne YD; Bastiaenen R; Gray B; Miles C; Ben-Haim Y; Papatheodorou S; Sharma S; Papadakis M; Devine B; Macfarlane PW; Behr ER
    Circulation; 2024 May; 149(21):1693-1695. PubMed ID: 38768273
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrocardiographic imaging of the arrhythmogenic substrate of Brugada syndrome: Current evidence and future perspectives.
    Galli A; Rizzo A; Monaco C; Salghetti F; Scala O; Chierchia GB; La Meir M; Brugada P; de Asmundis C
    Trends Cardiovasc Med; 2021 Jul; 31(5):323-329. PubMed ID: 32553882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemochromatosis, sinus node dysfunction and Brugada syndrome--a ménage a trois of findings in one and the same patient: coincidence or causality?
    Namdar M; Rodriguez-Manero M; Brugada P
    Acta Cardiol; 2012 Apr; 67(2):249-51. PubMed ID: 22641986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Chubb H; Cooklin M; Rosenthal E
    J Cardiovasc Electrophysiol; 2014 May; 25(5):547-548. PubMed ID: 24303843
    [No Abstract]   [Full Text] [Related]  

  • 20. High-frequency potentials developed in wavelet-transformed electrocardiogram as a novel indicator for detecting Brugada syndrome.
    Yodogawa K; Morita N; Kobayashi Y; Takayama H; Ohara T; Katoh T; Takano T
    Heart Rhythm; 2006 Dec; 3(12):1436-44. PubMed ID: 17161786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.